Design of Inhibitory Peptides of the Interaction between the E2 Protein of the Hepatitis C Virus and the CD81 and CD209 receptors
Infection through the Hepatitis C virus does not have a vaccine and treatment with pegylated interferon and ribavirin can fail; which is why it may cause chronic infection and, consequently, could develop liver failure or hepatocellular carcinoma. It has been described that virus-cell recognition oc...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Asociación Colombiana de Infectología
2021-04-01
|
Series: | Infectio |
Subjects: |